These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6800641)

  • 1. Dose responses of five hepatocarcinogens for the initiation of rat hepatocarcinogenesis.
    Imaida K; Shirai T; Tatematsu M; Takano T; Ito N
    Cancer Lett; 1981 Dec; 14(3):279-83. PubMed ID: 6800641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different responses to phenobarbital promotion in the development of gamma-glutamyltranspeptidase-positive foci in the liver of rats initiated with diethylnitrosamine, N-hydroxy-2-acetyl-aminofluorene and aflatoxin B1.
    Shirai T; Imaida K; Ohshima M; Fukushima S; Lee MS; King CM; Ito N
    Jpn J Cancer Res; 1985 Jan; 76(1):16-9. PubMed ID: 2857671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of various chemicals on the development of hyperplastic liver nodules in hepatectomized rats treated with N-nitrosodiethylamine or N-2-fluorenylacetamide.
    Ito N; Tatematsu M; Nakanishi K; Hasegawa R; Takano T; Imaida K; Ogiso T
    Gan; 1980 Dec; 71(6):832-42. PubMed ID: 7274629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of hyperplastic liver nodules in hepatectomized rats treated with 3'-methyl-4-dimethylaminoazobenzene, benzo[a]pyrene or phenobarbital before or after exposure to N-2-fluorenylacetamide.
    Hasegawa R; Tatematsu M; Tsuda H; Shirai T; Hagiwara A; Ito N
    Gan; 1982 Apr; 73(2):264-9. PubMed ID: 6288500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of cytochrome(s) P450 2B1/2 by phenobarbital in hepatic hyperplastic nodules induced by aflatoxin B1 or diethylnitrosamine plus 2-acetylaminofluorene in male F344 rats.
    Chen ZY; Eaton DL
    Toxicol Appl Pharmacol; 1991 Oct; 111(1):132-44. PubMed ID: 1949030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the promoting effects of various agents in induction of preneoplastic lesions in rat liver.
    Ito N; Tsuda H; Hasegawa R; Imaida K
    Environ Health Perspect; 1983 Apr; 50():131-8. PubMed ID: 6191977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-expression of protein kinase C delta is associated with a delay in preneoplastic lesion development in diethylnitrosamine-induced rat hepatocarcinogenesis.
    La Porta CA; Comolli R
    Carcinogenesis; 1995 May; 16(5):1233-8. PubMed ID: 7767990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Route-dependent, organ-specific effects of carcinogens on induction of hyperplastic liver nodules in rats.
    Hasegawa R; Tsuda H; Nakanishi K; Tatematsu M; Ito N
    Toxicol Lett; 1982 Dec; 14(3-4):229-35. PubMed ID: 7167983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance of Copenhagen rats to chemical induction of glutathione S-transferase 7-7-positive liver foci.
    Wood GA; Korkola JE; Lee VM; Sarma DS; Archer MC
    Carcinogenesis; 1997 Sep; 18(9):1745-50. PubMed ID: 9328170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic cell loss and proliferation induced by N-2-fluorenylacetamide, diethylnitrosamine, and aflatoxin B1 in relation to hepatoma induction.
    Nishizumi M; Albert RE; Burns FJ; Bilger L
    Br J Cancer; 1977 Aug; 36(2):192-7. PubMed ID: 199226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of carbon tetrachloride and azathioprine on diethylnitrosamine and N-2-fluorenylacetamide-induced hyperplastic liver nodule and hepatocellular carcinoma.
    Sakata T
    Acta Med Okayama; 1984 Dec; 38(6):511-24. PubMed ID: 6524446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of two sequential applications of initiators in the production of hepatomas in the rat: an examination of the Solt-Farber protocol.
    Potter VR
    Cancer Res; 1984 Jun; 44(6):2733-6. PubMed ID: 6722804
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanistic basis for nonlinearities and thresholds in rat liver carcinogenesis by the DNA-reactive carcinogens 2-acetylaminofluorene and diethylnitrosamine.
    Williams GM; Iatropoulos MJ; Jeffrey AM
    Toxicol Pathol; 2000; 28(3):388-95. PubMed ID: 10862555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different initiation protocols in the resistant hepatocyte model.
    Espandiari P; Robertson LW; Srinivasan C; Glauert HP
    Toxicology; 2005 Jan; 206(3):373-81. PubMed ID: 15588927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nodularin on the expression of glutathione S-transferase placental form and proliferating cell nuclear antigen in N-nitrosodiethylamine initiated hepatocarcinogenesis in the male Fischer 344 rat.
    Song KY; Lim IK; Park SC; Lee SO; Park HS; Choi YK; Hyun BH
    Carcinogenesis; 1999 Aug; 20(8):1541-8. PubMed ID: 10426804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing effect of inducers of liver microsomal enzymes on induction of hyperplastic liver nodules by N-2-fluorenylacetamide in rats.
    Tatematsu M; Nakanishi K; Murasaki G; Miyata Y; Hirose M; Ito N
    J Natl Cancer Inst; 1979 Dec; 63(6):1411-6. PubMed ID: 117197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aryl sulfotransferase IV deficiency in rat liver carcinogenesis initiated with diethylnitrosamine and promoted with N-2-fluorenylacetamide or its C-9-oxidized metabolites.
    Malejka-Giganti D; Ringer DP; Vijayaraghavan P; Kiehlbauch CC; Kong J
    Exp Mol Pathol; 1997 Apr; 64(2):63-77. PubMed ID: 9316585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent induction of preneoplastic liver cell foci by 2-acetylaminofluorene, phenobarbital and acetaminophen in F344 rats initially treated with diethylnitrosamine.
    Hasegawa R; Takahashi S; Imaida K; Yamaguchi S; Shirai T; Ito N
    Jpn J Cancer Res; 1991 Mar; 82(3):293-7. PubMed ID: 1902451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential quantitative studies on hyperplastic nodules in the liver of rats treated with carcinogenic chemicals.
    Tatematsu M; Murasaki G; Nakanishi K; Miyata Y; Shinohara Y; Ito N
    Gan; 1979 Feb; 70(1):125-30. PubMed ID: 87355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different inhibitory effects in the early and late phase of treatment with KAT-681, a liver-selective thyromimetic, on rat hepatocarcinogenesis induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
    Hayashi M; Tamura T; Kuroda J; Ohnota H; Shibata N; Akahane M; Kashida Y; Mitsumori K
    Toxicol Sci; 2005 Mar; 84(1):22-8. PubMed ID: 15564315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.